SCI holder plans Rule 144 sale of 5,000 shares

A holder of common stock of the SCI issuer filed a notice of a proposed Rule 144 sale of 5,000 shares.

Rhea-AI Filing Summary

A holder of common stock of the SCI issuer filed a notice of a proposed Rule 144 sale of 5,000 shares. The shares have an aggregate market value of $402,409.00 and will be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/13/2026. The 5,000 shares come from restricted stock awards acquired from the issuer between 03/05/2021 and 03/05/2025. The filing states that the seller does not know of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SCI Form 144 filing disclose about planned share sales?

The filing discloses a planned Rule 144 sale of 5,000 common shares of the SCI issuer. These shares have an aggregate market value of $402,409.00 and are scheduled for sale on the NYSE on or about 02/13/2026 through Morgan Stanley Smith Barney.

How were the SCI shares being sold under Rule 144 originally acquired?

The 5,000 SCI shares were acquired as restricted stock directly from the issuer. Acquisitions occurred on several dates between 03/05/2021 and 03/05/2025, with individual grants such as 903, 1,139, and 1,068 shares, all listed as having no special payment terms.

Which broker will handle the SCI Rule 144 stock sale?

The planned SCI stock sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is to be executed on the NYSE as the named exchange.

What is the aggregate market value of the SCI shares to be sold?

The aggregate market value of the SCI shares covered by this Form 144 notice is $402,409.00. This value relates specifically to the 5,000 common shares proposed for sale and does not refer to any other holdings or additional securities of the issuer.

How many SCI common shares are reported as outstanding in the Form 144?

The notice reports 139,223,665 common shares of the SCI issuer as outstanding. This figure provides context for the planned sale of 5,000 shares, which represents only a small portion relative to the total number of shares outstanding at the issuer level.

What representation does the seller make about SCI’s nonpublic information?

The seller represents that they do not know any material adverse information about SCI’s current or prospective operations that has not been publicly disclosed. This representation supports compliance with securities laws governing trades while in possession of nonpublic information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:06 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001464336
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SERVICE CORPORATION INTERNATIONAL
SEC File Number	001-06402
Address of Issuer	1929 Allen Parkway Houston TEXAS 77019
Phone	713-522-5141
Name of Person for Whose Account the Securities are To Be Sold	TAMMY MOORE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	402409.00	139223665	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2022	Restricted Stock	Issuer			903	03/05/2022	Not Applicable
Common	03/05/2024	Restricted Stock	Issuer			1139	03/05/2024	Not Applicable
Common	03/05/2021	Restricted Stock	Issuer			240	03/05/2021	Not Applicable
Common	03/05/2025	Restricted Stock	Issuer			1068	03/05/2025	Not Applicable
Common	02/17/2022	Restricted Stock	Issuer			424	02/17/2022	Not Applicable
Common	03/05/2023	Restricted Stock	Issuer			1226	03/05/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tammy R Moore
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)